IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Aug 1, 2025, 4:00 PM
1.280
-0.030 (-2.29%)
After-hours: Aug 1, 2025, 4:40 PM EDT
Six Flags Entertainment Market Cap
IGM Biosciences has a market cap or net worth of $78.98 million as of August 1, 2025. Its market cap has decreased by -88.76% in one year.
Market Cap
78.98M
Enterprise Value
-25.32M
1-Year Change
-88.76%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since September 18, 2019, IGM Biosciences's market cap has decreased from $702.07M to $78.98M, a decrease of -88.75%. That is a compound annual growth rate of -31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 78.85M | -78.30% |
| Dec 31, 2024 | 363.33M | -25.13% |
| Dec 29, 2023 | 485.25M | -33.39% |
| Dec 30, 2022 | 728.48M | -23.49% |
| Dec 31, 2021 | 952.10M | -66.22% |
| Dec 31, 2020 | 2.82B | 141.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |